Cardiovascular Systems, Inc. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was USD 61.45 million compared to USD 59.14 million a year ago. Net loss was USD 7.89 million compared to USD 8.97 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.23 a year ago.
For the six months, sales was USD 121.13 million compared to USD 117.51 million a year ago. Net loss was USD 18.52 million compared to USD 17.59 million a year ago. Basic loss per share from continuing operations was USD 0.47 compared to USD 0.45 a year ago.